Laryngopharyngeal Reflux Is a Potential Risk Factor for Juvenile-Onset Recurrent Respiratory Papillomatosis
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
30881982
PubMed Central
PMC6387692
DOI
10.1155/2019/1463896
Knihovny.cz E-zdroje
- MeSH
- biopsie MeSH
- dítě MeSH
- dospělí MeSH
- hypofarynx patofyziologie virologie MeSH
- infekce dýchací soustavy patofyziologie virologie MeSH
- infekce papilomavirem patofyziologie virologie MeSH
- laryngofaryngeální reflux patofyziologie virologie MeSH
- lidé MeSH
- mladiství MeSH
- Papillomaviridae patogenita MeSH
- předškolní dítě MeSH
- rizikové faktory MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Human papillomavirus (HPV) causes juvenile-onset recurrent respiratory papillomatosis (JORRP). Although HPV is common in children, the prevalence of JORRP is low. It is likely that other factors contribute to the pathogenesis of JORRP, during either activation or reactivation of a latent HPV infection. There is evidence that laryngopharyngeal reflux (LPR) might be such a risk factor for adult-onset recurrent respiratory papillomatosis. This study investigated if LPR might also be a risk factor for JORRP. MATERIALS AND METHODS: Children with JORRP of the larynx that required microlaryngoscopy at a tertiary referral hospital were included in this prospective case-series study from November 2015 to November 2017. Using immunohistochemistry, HPV infection and pepsin associated with LPR were diagnosed from laryngeal biopsies. RESULTS: Eleven children (aged 4-14 years) were analyzed. No patient had a history of immunodeficiency or tobacco smoke exposure. All patients underwent at least three previous surgeries due to JORRP and had been vaccinated against HPV in the past. Five children were treated using antivirotics and immunomodulators. The only known maternal risk factor was that three mothers were primiparous. All 11 samples were infected with HPV (type 6 or 11). Pathologic LPR was diagnosed in 5/11 children (45.5%). CONCLUSION: LPR may be a risk factor for JORRP, contributing to its development by activating or reactivating a latent HPV infection. Results are in accordance with those from our previous study in adults.
Department of Pathology University Hospital Ostrava 17 Listopadu 1790 70852 Ostrava Czech Republic
Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic
Zobrazit více v PubMed
Omland T., Akre H., Vãrdal M., Brøndbo K. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. The Laryngoscope. 2012;122(7):1595–1599. doi: 10.1002/lary.23327. PubMed DOI
Armstrong L. R., Preston E. J. D., Reichert M., et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clinical Infectious Diseases. 2000;31(1):107–109. doi: 10.1086/313914. PubMed DOI
Campisi P., Hawkes M., Simpson K. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope. 2010;120:1233–1245. PubMed
Seedat R. Y. The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho. International Journal of Pediatric Otorhinolaryngology. 2014;78(12):2113–2115. doi: 10.1016/j.ijporl.2014.09.017. PubMed DOI
Marsico M., Mehta V., Chastek B., Liaw K.-L., Derkay C. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sexually Transmitted Diseases. 2004;41(5):300–305. doi: 10.1097/OLQ.0000000000000115. PubMed DOI
Novakovic D., Cheng A. T. L., Baguley K., et al. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. The Laryngoscope. 2016;126(12):2827–2832. doi: 10.1002/lary.26005. PubMed DOI
Armstrong L. R., Derkay C. S., Reeves W. C. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP task force. Archives of Otolaryngology–Head & Neck Surgery. 1999;125(7):743–748. doi: 10.1001/archotol.125.7.743. PubMed DOI
Derkay C. S., Wiatrak B. Recurrent respiratory papillomatosis: a review. The Laryngoscope. 2008;118(7):1236–1247. doi: 10.1097/mlg.0b013e31816a7135. PubMed DOI
Derkay C. S. Task force on recurrent respiratory papillomas: a preliminary report. Archives of Otolaryngology--Head and Neck Surgery. 1995;121(12):1386–1391. doi: 10.1001/archotol.1995.01890120044008. PubMed DOI
Go C., Schwartz M. R., Donovan D. T. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Annals of Otology, Rhinology & Laryngology. 2003;112(4):298–302. doi: 10.1177/000348940311200402. PubMed DOI
Lacey C. J. N., Lowndes C. M., Shah K. V. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24:35–41. doi: 10.1016/j.vaccine.2006.06.015. PubMed DOI
Shah K. V., Stern W. F., Shah F. K., Bishai D., Kashima H. K. Risk factors for juvenile onset recurrent respiratory papillomatosis. The Pediatric Infectious Disease Journal. 1998;17(5):372–376. doi: 10.1097/00006454-199805000-00005. PubMed DOI
Szydłowski J., Jończyk-Potoczna K., Pucher B., et al. Prevalence of human papillomavirus (HPV) in upper respiratory tract mucosa in a group of pre-school children. Annals of Agricultural and Environmental Medicine. 2014;21(4):822–824. doi: 10.5604/12321966.1129940. PubMed DOI
Rintala M. A. M., Grénman S. E., Järvenkylä M. E., Syrjänen K. J., Syrjänen S. M. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the finnish HPV family study. Clinical Infectious Diseases. 2005;41(12):1728–1733. doi: 10.1086/498114. PubMed DOI
Formánek M., Jančatová D., Komínek P., Matoušek P., Zeleník K. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case–control study) Clinical Otolaryngology. 2017;42(3):597–601. doi: 10.1111/coa.12779. PubMed DOI
Taliercio S., Cespedes M., Born H., et al. Adult-onset recurrent respiratory papillomatosis: A review of disease pathogenesis and implications for patient counseling. JAMA Otolaryngology - Head and Neck Surgery. 2015;141(1):78–83. doi: 10.1001/jamaoto.2014.2826. PubMed DOI
Ruiz R., Achlatis S., Verma A., et al. Risk factors for adult-onset recurrent respiratory papillomatosis. The Laryngoscope. 2014;124(10):2338–2344. doi: 10.1002/lary.24730. PubMed DOI
McKenna M., Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. International Journal of Pediatric Otorhinolaryngology. 2005;69(5):597–605. doi: 10.1016/j.ijporl.2004.11.021. PubMed DOI
San Giorgi M. R. M., Helder H. M., Lindeman R.-J. S., de Bock G. H., Dikkers F. G. The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: a systematic review. The Laryngoscope. 2016;126(10):2330–2339. doi: 10.1002/lary.25898. PubMed DOI
Draganov P., Todorov S., Todorov I., Karchev T., Kalvatchev Z. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR® Green real-time PCR. International Journal of Pediatric Otorhinolaryngology. 2006;70(3):469–473. doi: 10.1016/j.ijporl.2005.07.018. PubMed DOI
Kashima H. K., Shah F., Lyles A., et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. The Laryngoscope. 1992;102(1):9–13. PubMed
Rabah R., Lancaster W. D., Thomas R., Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology. 2001;4(1):68–72. doi: 10.1007/s100240010105. PubMed DOI
Durzyńska J., Pacholska-Bogalska J., Kaczmarek M., et al. HPV genotypes in the oral cavity/oropharynx of children and adolescents: Cross-sectional survey in Poland. European Journal of Pediatrics. 2011;170(6):757–761. doi: 10.1007/s00431-010-1345-x. PubMed DOI PMC
Jiang A., Liang M., Su Z., et al. Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux. The Laryngoscope. 2011;121(7):1426–1430. doi: 10.1002/lary.21809. PubMed DOI
Crapko M., Kerschner J. E., Syring M., Johnston N. Role of extra-esophageal reflux in chronic otitis media with effusion. The Laryngoscope. 2007;117(8):1419–1423. doi: 10.1097/MLG.0b013e318064f177. PubMed DOI
Gibson Jr. W. S., Cochran W. Otalgia in infants and children - a manifestation of gastroesophageal reflux. International Journal of Pediatric Otorhinolaryngology. 1994;28(2-3):213–218. doi: 10.1016/0165-5876(94)90014-0. PubMed DOI
Nelson S. P., Chen E. H., Syniar G. M., Christoffel K. K. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric practice research group. JAMA Pediatrics. 1997;151(6):569–572. doi: 10.1001/archpedi.1997.02170430035007. PubMed DOI
Poelmans J., Tack J., Feenstra L. Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. Annals of Otology, Rhinology & Laryngology. 2002;111(10):933–938. doi: 10.1177/000348940211101013. PubMed DOI
Formánek Martin, Komínek Pavel, Matoušek Petr, Tomanova Radoslava, Urban Ondřej, Zeleník Karol. Comparison of three methods used in the diagnosis of extraesophageal reflux in children with chronic otitis media with effusion. Gastroenterology Research and Practice. 2015;2015:5. doi: 10.1155/2015/547959.547959 PubMed DOI PMC
Warner M. A., Warner M. E., Weber J. G. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology. 1993;78(1):56–62. doi: 10.1097/00000542-199301000-00010. PubMed DOI